Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer

Name: Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer
Published: 2011
License: Public Domain

Amgen · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

overall-survival

metastatic colorectal cancer, best supportive care, panitumumab, chemorefractory, wild-type kras, overall survival, phase 3, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer

Related documents